Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report
- PMID: 24489552
- PMCID: PMC3899707
- DOI: 10.1155/2013/568364
Anti-HPA-1b Mediated Posttransfusion Purpura: A Case Report
Abstract
Posttransfusion purpura (PTP) is an uncommon, but potentially fatal, transfusion reaction characterized by profound thrombocytopenia and bleeding. PTP is caused by alloimmunization to human platelet specific antigens following blood component transfusion. Although there is evidence of a wide serological spectrum of culprit antibodies implicated, Anti-human-platelet-antigen- (HPA-) 1a is the most common antibody in cases reported. We report a case of posttransfusion purpura in an African American. The patient was negative for HPA-1a antibodies, but anti-HPA-1b was identified with a platelet phenotype of HPA-1a/HPA-1a. Although less common, HPA-1b antibody may be an important consideration in posttransfusion purpura diagnosed in patients of African descent.
Figures
References
-
- Metcalfe P. Platelet antigens and antibody detection. Vox Sanguinis, Supplement. 2004;87(1):S82–S86. - PubMed
-
- Chapman JF, Murphy MF, Berney SI. Post-transfusion purpura associated with anti-Baka and anti-Pl(A2) platelet antibodies and delayed haemolytic transfusion reaction. Vox Sanguinis. 1987;52(4):313–317. - PubMed
-
- Goldberger A, Kolodziej M, Poncz M, Bennett JS, Newman PJ. Effect of single amino acid substitutions on the formation of the PI(A) and bak alloantigenic epitopes. Blood. 1991;78(3):681–687. - PubMed
-
- Waters HA. Immune thrombocytopenias. In: Hoffbrand VA, Lewis SM, Tuddenham EGD, editors. Postgraduate Haematology. 4th edition. New York, NY, USA: Oxford Univeristy Press; 2001. pp. 601–603.
-
- Cimo PL, Aster RH. Post-transfusion purpura: successful treatment by exchange transfusion. The New England Journal of Medicine. 1972;287(6):290–292. - PubMed
LinkOut - more resources
Full Text Sources
Other Literature Sources
